Novan, Inc. (the "Company" or "Novan") (NASDAQ:NOVN) today announced the closing of the Company's previously announced underwritten public offering (the "Offering") of 3,636,364 shares of common stock at a public offering price of $11.00 per share.
Novan, Inc. today announced that the Company has established a strategic alliance with Orion Corporation, a Finnish full-scale pharmaceutical company with broad experience in manufacturing.....